OLAMLO HCT 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

olamlo hct 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack

accord healthcare pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.9 mg - tablet, film coated - excipient ingredients: lactose monohydrate; isopropyl alcohol; magnesium stearate; pregelatinised maize starch; povidone; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olamlo hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

OLAMLO HCT 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

olamlo hct 40/10/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/25 mg film-coated tablet blister pack

accord healthcare pty ltd - hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.9 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; povidone; lactose monohydrate; isopropyl alcohol; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - olamlo hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

OLAMLO HCT 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

olamlo hct 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack

accord healthcare pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.95 mg - tablet, film coated - excipient ingredients: silicified microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; povidone; isopropyl alcohol; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - olamlo hct indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

OLAMLO HCT 40/5/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/25 mg film-coated tablet blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

olamlo hct 40/5/25 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/25 mg film-coated tablet blister pack

accord healthcare pty ltd - amlodipine besilate, quantity: 6.95 mg; hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; silicified microcrystalline cellulose; isopropyl alcohol; povidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olamlo hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

olamlo hct 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack

accord healthcare pty ltd - amlodipine besilate, quantity: 6.95 mg; olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; silicified microcrystalline cellulose; isopropyl alcohol; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - olamlo hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

Amcofen 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Irska - engleski - HPRA (Health Products Regulatory Authority)

amcofen 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5.125.0 mg/tablet - milbemycin oxime, combinations

Amcofen 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg Irska - engleski - HPRA (Health Products Regulatory Authority)

amcofen 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 2.5,25 mg/tablet - milbemycin oxime, combinations

Mektix 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Irska - engleski - HPRA (Health Products Regulatory Authority)

mektix 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5,125 mg/tablet - milbemycin oxime, combinations

Mektix 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg Irska - engleski - HPRA (Health Products Regulatory Authority)

mektix 2.5 mg/25 mg film-coated tablets for small dogs and puppies weighing at least 0.5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 2.5,25 mg/tablet - milbemycin oxime, combinations

Milgusto 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg Irska - engleski - HPRA (Health Products Regulatory Authority)

milgusto 12.5 mg/125 mg film-coated tablets for dogs weighing at least 5 kg

krka, d.d., novo mesto - milbemycin oxime; praziquantel - film-coated tablet - 12.5/125 mg/tablet - milbemycin oxime